TTR mouse Monoclonal Antibody(9A6)

This gene encodes transthyretin, one of the three prealbumins including alpha-1-antitrypsin, transthyretin and orosomucoid. Transthyretin is a carrier protein; it transports thyroid hormones in the plasma and cerebrospinal fluid, and also transports retinol (vitamin A) in the plasma. The protein consists of a tetramer of identical subunits. More than 80 different mutations in this gene have been reported; most mutations are related to amyloid deposition, affecting predominantly peripheral nerve and/or the heart, and a small portion of the gene mutations is non-amyloidogenic. The diseases caused by mutations include amyloidotic polyneuropathy, euthyroid hyperthyroxinaemia, amyloidotic vitreous opacities, cardiomyopathy, oculoleptomeningeal amyloidosis, meningocerebrovascular amyloidosis, carpal tunnel syndrome, etc.

Introducing the TTR Mouse Monoclonal Antibody (9A6), a cutting-edge product designed to revolutionize the field of biomedical research. This highly advanced antibody is meticulously engineered to specifically target and bind to Transthyretin (TTR), a protein associated with various pathological conditions.

The TTR Mouse Monoclonal Antibody (9A6) boasts exceptional specificity and sensitivity, enabling precise detection and quantification of TTR in a wide range of biological samples. Its superior affinity ensures reliable and accurate results, making it an invaluable tool for scientists and researchers alike.

Crafted with utmost precision, this monoclonal antibody exhibits exceptional stability and reproducibility, guaranteeing consistent performance across multiple experiments. Its robust formulation ensures prolonged shelf life, allowing for long-term storage without compromising its efficacy.

The TTR Mouse Monoclonal Antibody (9A6) is meticulously validated through rigorous quality control measures, ensuring its reliability and reproducibility. Its exceptional performance has been demonstrated in numerous studies, making it a trusted choice for researchers worldwide.

This groundbreaking antibody opens up new avenues for investigating the role of TTR in various diseases, including neurodegenerative disorders and amyloidosis. Its versatility extends to a wide range of applications, including Western blotting, immunohistochemistry, and enzyme-linked immunosorbent assays (ELISA).

In summary, the TTR Mouse Monoclonal Antibody (9A6) is a state-of-the-art product that offers unparalleled specificity, sensitivity, and reliability. With its exceptional performance and versatility, it is poised to revolutionize the field of biomedical research, empowering scientists to unravel the mysteries of TTR-related diseases and pave the way for innovative therapeutic interventions.